This reduction in tumor burden coincided with reduced tumor cell proliferation rather than increased apoptosis, and was associated with a reduction of CD31+ endothelial cells (Fig. 2d and Supplementary Fig. 2d). Here, PECAM1 is linked to neoplasm.